Skip to main content

International Psoriasis Council

Advancing Knowledge. Improving Care.

Understanding the Impact of Psoriasis on Women’s Lives

Mahira El Sayed, MSc, MD

Ain Shams University

Cairo, Egypt

IPC Board Member

Bio

As a Professor of Dermatology and Venereology at Ain Shams University, Head of the Egyptian Board of Examinations, and member of the Ministry of Health committee for biological treatment of psoriasis, Dr. El Sayed has been committed to improving outcomes for psoriasis patients throughout her career. In a recent interview, Dr. El Sayed shared her clinical expertise in managing psoriasis in women at different life stages.

Tailored Management Strategies are Required for Women at Different Life Stages

Women with psoriasis face many considerations throughout their lives, such as during puberty, pregnancy, post-partum, and menopause. The impact of hormonal fluctuations, psychosocial stressors, and the need for tailored treatment strategies to address disease activity at different life stages make psoriasis more complex to manage in women.

“I have to consider a married woman at any age who has not had children. A lot of pregnancies are unplanned,” says Dr. El Sayed. For women of childbearing age, Dr. El Sayed reminds healthcare providers to consider safer medications during pregnancy. For example, acitretin is absolutely contraindicated and requires a prolonged period off the medication before pregnancy, whereas methotrexate, although also unsafe during pregnancy, can be discontinued and reinitiated more quickly.

Although psoriasis typically improves with pregnancy and tends to flare in the post-partum period. Dr. El Sayed notes that there are exceptions to this pattern. Dr. El Sayed prefers treating with certolizumab, an Fc-free anti-tumor necrosis factor (anti-TNF) drug, if available for women with moderate-severe psoriasis who are pregnant or breastfeeding. But if not readily available, her alternative is cyclosporine, which is not secreted in breast milk. As a reminder, she reminds providers to check the patient’s blood pressure while on cyclosporine to ensure the mother does not develop post-partum eclampsia. Other options for pregnancy and lactation for milder cases may include narrowband UVB and topical therapies. 

A clinical scenario for a post-partum breastfeeding patient in a psoriasis flare may involve clinical visits every two months while on cyclosporine until breastfeeding ends. Then, overlapping another treatment, such as a biologic, while gradually tapering off cyclosporine.

Fortunately, according to Dr. El Sayed, all biologics and biosimilars are readily available in Egypt, but they remain expensive. National health insurance, private insurance programs, and state sponsorships may reimburse some or all of the cost. However, some patients may still have to pay out-of-pocket expenses. Biologics are life-saving for patients with psoriasis but may still be cost-prohibitive to some.

Psoriasis imposes a significant burden of disease on women's lives, not just physically but emotionally and socially.

Women with Psoriasis Suffer from Decreased Quality of Life

The burden of psoriasis in women contributes to lower happiness, more stress, more loneliness, and higher stigmatization. Social stigma can affect women with psoriasis more profoundly than men. “The cosmetic appearance of the disease and its exposed areas can affect the patient’s quality of life, well-being, psyche, and psychology,” says Dr. El Sayed.

Women of childbearing age, in particular, may feel added pressure. Some are brought in by their families who worry about the condition’s impact on their chances of marriage. Others may already be married but feel self-conscious, ashamed, or embarrassed about revealing their condition to their partners. To address these concerns, Dr. El Sayed encourages patients to bring their partners or spouses to appointments, where she educates them about the non-contagious nature of psoriasis. In some cases, psoriasis can even prevent women from seeking marriage altogether, as they may fear judgment or rejection due to their skin condition.

Future Directions for Women with Psoriasis

Psoriasis imposes a significant burden of disease on women’s lives, not just physically but emotionally and socially. Healthcare providers caring for this population must remain attentive, adjusting treatment plans to accommodate the various life stages women experience. Since conducting clinical trials in pregnant women with psoriasis remains challenging due to ethical concerns, treatment for this vulnerable patient population will continue to rely on clinical experience as well as a deep understanding of drug mechanisms and pharmacology.

Comments are closed.

Categories

Recent Posts

FDA Labeling Now Aligns with the IPC and NPF Joint Position Statement on Tuberculosis Testing

Dose Reduction of IL-17 and IL-23 Inhibitors: Are We Ready for Tailored Dosing in the Era of Disease Modification?

Remembering Dr. Craig Leonardi

Also Read

Subscribe to the IPC Newsletter

Stay up-to-date on the latest research, news, and upcoming events right in your inbox.

What's New

Remembering Dr. Craig Leonardi

The International Psoriasis Council (IPC) remembers Dr. Craig Leonardi, founding member and former President, whose research shaped modern psoriasis treatment.

Read More »

Look Beyond My Skin: World Psoriasis Day 2026

World Psoriasis Day, observed each year on October 29, was launched by the International Federation of Psoriasis Associations (IFPA) in 2004 to give a voice to the more than 125 million people worldwide living with psoriasis and psoriatic arthritis. To mark this year’s observance, IPC joined the Latin American Society of Psoriasis and Dermoimmunology (SOLAPSO) and the Skin Inflammation and Psoriasis International Network (SPIN) to create a video series around the theme “Look Beyond My Skin,” featuring voices from all three organizations. Missed the videos on social media? Watch the full series on the IPC YouTube channel.

WATCH NOW

Thursday, October 29, 2026

Introducing Take Two with IPC: Expert Talks in Two Minutes

Take Two with IPC gives a longer presentation a second life in two minutes. Each video takes an expert talk IPC has already published (a Take Ten recording or a symposium presentation) and condenses the clinical substance. The series launched this month alongside the World Psoriasis Day campaign with four videos on pediatric psoriasis: Psoriasis Look-Alikes and Anti-TNF-α Induced Skin Eruptions with IPC Board Member Amy Paller, MS, MD; Conventional Therapies with IPC Councilor Mona El-Kalioby, MBBCh, MSc, MD; and Phototherapy in Pediatric Psoriasis with Fernando Valenzuela, MD. New Take Two videos will be featured each month, drawn from the Take Ten with IPC library and recordings from IPC symposia, with a link to the full presentation for each.

WATCH NOW

Thursday, October 29, 2026

Videos Now Available from the Eczema and Psoriasis Research Incubator

Select presentations from the Eczema and Psoriasis Research Incubator: Cross-Disciplinary Innovation Forum, hosted by the International Eczema Council (IEC) and International Psoriasis Council (IPC) at the 55th Annual European Society for Dermatological Research (ESDR) Meeting, are now available. Topics include disease endotypes, atopic dermatitis-psoriasis overlap, cardiovascular risk in psoriasis, and genetic susceptibility.

WATCH NOW

Monday, October 26, 2026

Sex Differences in Psoriasis

In this Take Ten with IPC video, Juul van den Reek and PhD candidate Liana Barenbrug discuss sex differences in psoriasis, why these distinctions matter, what current research tells us, and which areas should be prioritized in future psoriasis research.

WATCH NOW

Thursday, October 1, 2026